Media

BONESUPPORT™ Raises $37 million (SEK 327 million) to Drive Product Sales and Deliver Further Value from CERAMENT™ Injectable Drug Eluting Bioceramic Platform

Altimmune Announces Poster Presentation of HepTcell Program at 2017 Keystone Symposia Conference

Nordic Nanovector and Heidelberg Pharma enter collaboration to develop novel antibody-drug conjugates (ADCs) targeting leukaemias

Onxeo Reports Third Quarter 2016 Financial Information and Provides Business Update

Interim Report January-September 2016

GenSight Biologics reports its cash position as of September 30, 2016

BrainCool makes a strategic acquisition in purchasing all assets of the American medical cooling company Benechill Inc

Nordic Nanovector ASA: Extraordinary General Meeting held

Nordic Nanovector announces the appointment of Joanna Horobin, MD, as Non-executive Board Director